Study selection
Studies evaluating the use of amphotericin B bladder irrigation for treatment of asymptomatic candiduria were eligible for inclusion. The outcome of interest was candiduria clearance, which was determined qualitatively or quantitatively by the presence of Candida species in at least two urine samples. To be eligible, studies could be comparative (amphotericin B bladder irrigation with another treatment), single-armed, or dose-finding comparing different dosing regimes of amphotericin B bladder irrigation.
All the included studies were prospective in design. Included patients were hospitalised adults with urine cultures showing the presence of Candida albicans and Candida species; in some cases, the species identification was "unknown". Where relevant, fluconazole was the comparator drug. The dose of amphotericin B bladder irrigation varied, depending on continuous (10 to 50mg/L) or intermittent (1mg/200mL to 30mg/100mL) treatment.
The authors did not state how the papers were selected for the review.
Assessment of study quality
Validity was assessed but no particular scale was used. The level of blinding, randomisation, control groups and study design were considered.
The authors did not state how many reviewers performed the validity assessment.
Data extraction
Data on candiduria clearance and treatment failure were extracted to calculate odds ratios (OR) with corresponding 95% confidence intervals (CI).
The authors did not state how many reviewers performed the data extraction
Methods of synthesis
Meta-analysis was used to calculate pooled odds ratios with corresponding 95% confidence intervals for persistence of candiduria (candiduria clearance). Pooled outcomes were reported separately for comparisons of: amphotericin B bladder irrigation (continuous or intermittent) versus fluconazole at 24 hours and five days after treatment; continuous amphotericin B bladder irrigation versus intermittent amphotericin B bladder irrigation at 24 hours and five days after treatment; and continuous amphotericin B bladder irrigation for five days or more versus treatment of less than five days.
Results of the review
Nine studies were included in the review (n=377 patients; range 10 to 88). All studies were open-label; five were reported as randomised controlled trials. Included studies varied in duration of follow-up (at discharge or between seven to 30 days).
Amphotericin B bladder irrigation (continuous or intermittent) versus fluconazole: Amphotericin B bladder irrigation was associated with lower rates of candiduria persistence 24 hours after treatment, but this result did not achieve statistical significance (OR 0.57, 95% CI 0.32 to 1.00). There were no differences in candiduria persistence between the treatment groups five days after treatment.
Continuous versus intermittent amphotericin B bladder irrigation treatment: Continuous bladder irrigation with amphotericin B was superior to intermittent treatment at seven days after treatment (OR 0.52, 95% CI 0.29 to 0.94), but at 24 hours after the end of treatment. Continuous amphotericin B bladder irrigation for five days or more had lower candiduria persistent rates than intermittent treatment, but did not achieve statistical significance.
